Charities Canada Science & Technology Canadian Myeloma Research Group
CA

Canadian Myeloma Research Group

Science & Technology Concord, ON BN 788293496RR0001 · CRA Sign up to see website
Claim this charity
Ready to give?
100% goes to Canadian Myeloma Research Group

GiveRadar doesn't take a cut. We couldn't find a direct donate page, so visit their site.

Visit www.cmrg.ca
56
Integrity Assessment
Partial transparency
56/100 · methodology

About Canadian Myeloma Research Group

Canadian Myeloma Research Group is a science technology organization based in CONCORD, Canada. Annual revenue: $4.1 million. Registration: 788293496RR0001.

Headquarters
Concord, ON
Foundation type
Charitable organization
Size
medium

Focus areas & reach

· What they work on and where
Science & Technology

How it stacks up against peers

· vs. 5 similar science & technology in Canada
Program spending This charity: 96%
Peer average: 74%
Integrity Assessment This charity: 56
Peer average: 51

Red flags

· All clear
CRA registration revocation
OFAC / EU / UN sanctions
Open investigations
Governance scandals
Related-party deals
Excessive exec comp

Where every C$1 goes

C$0.96
Program expensesC$0.96 (C$1.9 million)
96% to programs beats the peer average (74%) and beats the Charity Navigator "highly efficient" threshold (75%).

Common questions

· Auto-generated from filings + methodology

Canadian Myeloma Research Group is a registered science & technology nonprofit based in Concord, ON, Canada. It is registered with the Canada Revenue Agency (CRA). Its registration number is 788293496RR0001. It has a GiveRadar Integrity Assessment of 56/100 (Partial transparency), indicating some public data is available but key signals are missing. This is above the average of 51/100 for science & technology charities in Canada. The organization reports C$4M in annual revenue. 7 officers and directors are publicly disclosed.

Canadian Myeloma Research Group has a GiveRadar Integrity Assessment of 56/100. This score combines five components: Registration (20 pts), Financial Transparency (30 pts), Governance (20 pts), Contact Availability (10 pts), and Data Recency (20 pts), with negative adjustments for any red flags. A score of 56 ('Partial transparency') means some public data is on file but key signals are missing - worth a closer look before donating. The charity allocates 96% of expenses to programs, which contributes positively to its score. For comparison, the average integrity assessment for science & technology charities in Canada is 51/100.

Canadian Myeloma Research Group is located in Concord, ON, Canada. Its registered address is 202B - 8400 Jane St, Canada.

Based on official tax filings, Canadian Myeloma Research Group has C$4M in annual revenue. It allocates 96% of expenses to programs and services. This is above the average of 74% for science & technology charities in Canada. Create a free GiveRadar account to view the complete financial breakdown with year-over-year trends.

Canadian Myeloma Research Group is classified as a Science & Technology organization, registered in Canada. It operates as a Charitable organization. By size, it is categorized as a medium organization. It has C$4M in annual revenue. The organization has 7 disclosed officers and directors.

Canadian Myeloma Research Group has a GiveRadar Integrity Assessment of 56/100. We recommend reviewing the full profile before making a donation decision. The organization is overseen by the CRA. 96% of expenses go to programs. The peer average is 74%. Visit the Canadian Myeloma Research Group profile on GiveRadar for full details before deciding. GiveRadar provides data for research purposes and does not endorse any organization. Always do your own due diligence.

Canadian Myeloma Research Group is a science technology organization based in CONCORD, Canada. Annual revenue: $4.1 million. Registration: 788293496RR0001. Canadian Myeloma Research Group is classified as a science & technology organization registered in Canada.

Among science & technology charities registered in Canada: Canadian Myeloma Research Group's GiveRadar Integrity Assessment of 56/100 is above the peer average of 51/100. It allocates 96% of expenses to programs, above the peer average of 74%. Its annual revenue of C$4M is comparable to the peer average of C$5M.

Canadian Myeloma Research Group is a registered charity in Canada. Donations to registered Canadian charities are eligible for tax credits on your federal and provincial income tax returns. The federal credit is 15% on the first $200 and 29% on amounts above $200. Keep your official donation receipt for tax filing.

Verified against 4 official sources, last refreshed .

Annual revenue
C$1M-C$10M
96% to programs
Source: CRA (Canada) (FY2023) why this matters
Unlock exact figures

Filing history

2 years on file from CRA (Canada) (FY2023): revenue, expenses, program spending, assets, and liabilities by fiscal year.

Years on record: FY2023, FY2023.
Financial details are free - with a GiveRadar account

See 5 years of revenue, expense breakdowns, and balance sheet.

Sign up to view
Already have an account? Log in
No credit card · Takes 20 seconds

Taxes

Tax-deductibility for donors

Canadian donations are deductible if CANADIAN MYELOMA RESEARCH GROUP is registered with the CRA as a charity. The charity issues an official donation receipt.

Always confirm tax treatment with the charity directly or your tax advisor before donating.

Leadership

AR
Arleigh Robertson McCurdy
Director

Officers & trustees (7)

Source: Public filings

AR
Arleigh R•••••••• M••••••
Director
CH
Christopher V•••••
Director
DA
Darrell W••••
Chair
DO
Donna R••••
Chief Medical Officer
LO
Lorelei D••••••••
Director
SO
Sofia T•••••••••
Director
SU
Suzanne R••••••
Director
Full names, contact details & compensation

Free with an account.

Unlock

Latest news

From global news sources

10 articles found

From global news sources

Sentiment

Neutral

Blood cancer patients plead officials to resume pricing talks for cutting-edge treatment - The Globe and Mail

www.theglobeandmail.com · · Neutral

Obituary information for John David McMullen - Circle Of Life Cremation And Burial Centre Inc

www.circleoflifecbc.com · · Neutral

Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial - Nature

www.nature.com · · Neutral

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial - Nature

www.nature.com · · Neutral

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database - Nature

www.nature.com · · Neutral

Attrition Rates in Multiple Myeloma Increase After Each Subsequent Line of Therapy - Cancer Nursing Today

www.cancernursingtoday.com · · Neutral

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database - Nature

www.nature.com · · Neutral

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis - Nature

www.nature.com · · Neutral

Arthur Lyon Obituary - Victoria, BC - Dignity Memorial

www.dignitymemorial.com · · Neutral

Kelowna's 6th annual Multiple Myeloma March raises critical funds over the weekend - KelownaNow

www.kelownanow.com · · Neutral

Activity timeline

Filings and press mentions, merged

Blood cancer patients plead officials to resume pricing talks for cutting-edge treatment - The Globe and Mail
Nov 2025
www.theglobeandmail.com
Obituary information for John David McMullen - Circle Of Life Cremation And Burial Centre Inc
Mar 2025
www.circleoflifecbc.com
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a s
Sep 2024
www.nature.com
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial - Nature
Jan 2024
www.nature.com
Form filed
C$4.1M revenue
FY2023
CRA
Form filed
C$4.1M revenue
FY2023
CRA
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple mye
Dec 2023
www.nature.com
Attrition Rates in Multiple Myeloma Increase After Each Subsequent Line of Therapy - Cancer Nursing Today
Oct 2023
www.cancernursingtoday.com
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadi
Sep 2023
www.nature.com
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis - Nature
Jul 2023
www.nature.com
Arthur Lyon Obituary - Victoria, BC - Dignity Memorial
Nov 2022
www.dignitymemorial.com
Kelowna's 6th annual Multiple Myeloma March raises critical funds over the weekend - KelownaNow
Sep 2021
www.kelownanow.com

No reviews yet. Be the first to share your experience.

Have you donated or volunteered here?

Share your experience - it takes 30 seconds. Verified reviews help other donors decide.

Sign up to write a review

Peer charities

Other science & technology in Canada, by integrity assessment

Charity Score Revenue Program %
Canadian Myeloma Research Group This page 56 C$4.1 million 96%
The Fields Institute for Research in Mathematical Sciences 53 C$9.0 million 73%
Rugged Coast Research Society 53 C$2.3 million 81%
Canada Fetal Alcohol Spectrum Disorder Research Network 50 C$1.3 million 79%
Homewood Research Institute 50 C$1.8 million 73%
Pacific Parkinson'S Research Institute - Vancouver, Canada Society 49 C$1.4 million 63%

Sources and verification

Refreshed

Registration and legal identity
Canada Revenue Agency (CRA) - List of Charities
Financial filings
CRA T3010 Registered Charity Information Returns - Fiscal year 2023 most recent on file.
Officers and trustees
Canada Revenue Agency (CRA) - List of Charities - 7 disclosed in the public registry.
News and media coverage
GDELT Project + Google News

Data freshness

Last updated
Apr 21, 2026
Profile completeness
85%

What we don't know

Honest gaps - our score reflects transparency, not impact

Executive compensation
Top-officer pay not disclosed
Mission statement
No self-published statement of purpose
Programs & projects
No named programs listed by the charity
Direct contact
No email or phone published
Operating reach
Countries where programs run not specified
Founding date
Year the organisation was founded not on file

Methodology

GiveRadar combines public registry filings, ProPublica Nonprofit Explorer, Charity Navigator, GuideStar, and news archives into a single 0-100 integrity assessment. We don't take a cut of any donation, ever.

Read full methodology

Quick facts about Canadian Myeloma Research Group

What is Canadian Myeloma Research Group?
Canadian Myeloma Research Group is a science & technology charitable organization based in Concord, Canada. Canadian Myeloma Research Group is a science technology organization based in CONCORD, Canada. Annual revenue: $4.1 million. Registration: 788293496RR0001.
Where is Canadian Myeloma Research Group located?
Headquartered in Concord, Canada.
What is Canadian Myeloma Research Group's annual budget?
Annual revenue for fiscal year 2023 is approximately C$1M-C$10M. 96% of expenses go to program services.
Is Canadian Myeloma Research Group trustworthy?
Canadian Myeloma Research Group has a GiveRadar Integrity Assessment of 56 out of 100 (Partial transparency). The score reflects public-data transparency: registration, financial disclosure, governance, contact details, and how recently data was refreshed. It does not measure program impact.
What is Canadian Myeloma Research Group's registration number?
Registration: 788293496RR0001 (Canada).
What is Canadian Myeloma Research Group's website?
https://www.cmrg.ca
Are donations to Canadian Myeloma Research Group tax-deductible?
Donations may be tax-deductible for residents of Canada under local rules. US donors should check whether the charity has an equivalency-determination letter or a US-based fiscal sponsor before claiming a deduction.